Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026)

Arvinas (ARVN) posted quarterly Depreciation & Amortization (CF) of $700000.0 for Q1 2026, little changed year-over-year from $700000.0 in Q1 2025, and little changed quarter-over-quarter from $700000.0 in Q4 2025.

Analysis

Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Arvinas' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $700000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $3.0 million (down 26.83% YoY), while the FY2025 annual figure was $3.0 million, down 34.78% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $700000.0, roughly flat from $700000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.7 million in Q4 2022, with the low at $700000.0 in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $1.2 million (2023), against an average of $1.1 million.
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) surged 36.36% in 2022, then sank 41.67% in 2025.
  • Arvinas' Depreciation & Amortization (CF) stood at $1.7 million in 2022, then dropped by 29.41% to $1.2 million in 2023, then fell by 8.33% to $1.1 million in 2024, then sank by 36.36% to $700000.0 in 2025, then changed by 0.0% to $700000.0 in 2026.
  • Business Quant data shows ARVN's Depreciation & Amortization (CF) at $700000.0 in Q1 2026, $700000.0 in Q4 2025, and $800000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Arvinas 609.77 Mn 41.87 Mn - 700,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 700,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.10 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 1.70 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 1.50 Mn
Mar 31, 2022 1.50 Mn
Dec 31, 2021 1.30 Mn
Sep 30, 2021 1.20 Mn